https://doi.org/10.1016/j.cgh.2011.06.032
M
Mark T. Osterman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
289
Papers
4.6K
Citations
36
h-index
67
i10-index
Mark T. Osterman is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 36, co-authored 246 publications.
ORCID: 0000-0002-9962-1143Papers by this author
worksNo Increased Risk of Myocardial Infarction Among Patients With Ulcerative Colitis or Crohn's Disease
2011 · Clinical Gastroenterology and Hepatology · 92 citations
Measurement of Inflammatory Bowel Disease Symptoms
2015 · Inflammatory Bowel Diseases · 14 citations
https://doi.org/10.1097/mib.0000000000000496
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases
2020 · Digestive Diseases and Sciences · 8 citations
https://doi.org/10.1007/s10620-020-06669-6
Su1766 OZANIMOD IS MORE EFFECTIVE IN ADVANCED THERAPY–NAIVE ULCERATIVE COLITIS PATIENTS WITH ENDOSCOPICALLY MODERATE VS SEVERE DISEASE REGARDLESS OF BASELINE PATIENT-REPORTED OUTCOMES OR PRIOR IMMUNOMODULATOR EXPOSURE
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)02330-8
Su1791 DURABILITY OF RESPONSE IN DELAYED RESPONDERS TO OZANIMOD IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY NUMBER OF PRIOR BIOLOGICS: 3-YEAR UPDATE FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)02355-2
Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis
2026 · Inflammatory Bowel Diseases · 0 citations
https://doi.org/10.1093/ibd/izaf319
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat